https://www.biospace.com/employer/3075214/definium-therapeutics Definium Therapeutics en-US Tue, 03 Mar 2020 13:06:11 GMT https://www.biospace.com/mindmed-lists-on-neo-to-become-world-s-first-psychedelic-pharmaceutical-company-to-go-public NEO is pleased to announce it has granted final approval to Mind Medicine Inc., the leading neuro-pharmaceutical company for psychedelic-inspired medicines, to make its global public markets debut. Tue, 03 Mar 2020 13:06:11 GMT https://www.biospace.com/mindmed-lists-on-neo-to-become-world-s-first-psychedelic-pharmaceutical-company-to-go-public https://www.biospace.com/leading-psychedelic-pharmaceutical-company-mindmed-forms-new-board-committee-to-evaluate-acquisitions-and-scientific-collaborations John Hopkins professor and psychedelics expert Matthew Johnson to act as senior advisor to committee Thu, 12 Mar 2020 09:06:12 GMT https://www.biospace.com/leading-psychedelic-pharmaceutical-company-mindmed-forms-new-board-committee-to-evaluate-acquisitions-and-scientific-collaborations https://www.biospace.com/mindmed-reports-2019-year-end-results-and-corporate-update Mind Medicine Inc. announced the release of its audited consolidated financial statements and accompanying management's discussion and analysis for the period from May 30, 2019, date of incorporation, to December 31, 2019. Mon, 30 Mar 2020 22:26:05 GMT https://www.biospace.com/mindmed-reports-2019-year-end-results-and-corporate-update https://www.biospace.com/mindmed-acquires-exclusive-license-to-eight-clinical-trials-of-lsd-partners-with-world-leading-psychedelic-research-laboratory-at-university-hospital-basel Multi-year deal gives MindMed access to largest collection of clinical trials & knowhow for LSD psychedelic research including a Phase 2 clinical trial of LSD for the treatment of anxiety Wed, 01 Apr 2020 11:06:06 GMT https://www.biospace.com/mindmed-acquires-exclusive-license-to-eight-clinical-trials-of-lsd-partners-with-world-leading-psychedelic-research-laboratory-at-university-hospital-basel https://www.biospace.com/mindmed-initiates-dosing-in-human-safety-study-of-novel-treatment-for-opioid-addiction-18-mc Mind Medicine (MindMed) Inc. (NEO: MMED)(OTC: MMEDF), the leading psychedelic pharmaceutical company, has begun dosing the first subject in an additional Phase 1 human safety trial of 18-MC. Fri, 17 Apr 2020 02:06:04 GMT https://www.biospace.com/mindmed-initiates-dosing-in-human-safety-study-of-novel-treatment-for-opioid-addiction-18-mc https://www.biospace.com/mindmed-announces-u-s-trading-on-the-otcqb-venture-market-under-symbol-mmedf Mind Medicine Inc., the leading psychedelic pharmaceutical company, is pleased to announce that the Company has graduated from the OTC Pink Open Market to the OTCQB Venture Market. Fri, 17 Apr 2020 10:06:04 GMT https://www.biospace.com/mindmed-announces-u-s-trading-on-the-otcqb-venture-market-under-symbol-mmedf https://www.biospace.com/repeat-mindmed-initiates-dosing-in-human-safety-study-of-novel-treatment-for-opioid-addiction-18-mc Mind Medicine Inc., the leading psychedelic pharmaceutical company, has begun dosing the first subject in an additional Phase 1 human safety trial of 18-MC. Fri, 17 Apr 2020 12:06:05 GMT https://www.biospace.com/repeat-mindmed-initiates-dosing-in-human-safety-study-of-novel-treatment-for-opioid-addiction-18-mc https://www.biospace.com/mindmed-promotes-jeanne-bonelle-to-executive-vice-president-technical-operations Company is actively developing and scaling manufacturing processes for 18-MC and LSD APIs to be used in the company's future drug trials Mon, 20 Apr 2020 09:06:02 GMT https://www.biospace.com/mindmed-promotes-jeanne-bonelle-to-executive-vice-president-technical-operations https://www.biospace.com/psychedelic-pharmaceutical-company-mindmed-develops-lsd-neutralizer-technology-to-shorten-and-stop-lsd-trips Advances Discovered in Collaboration with University Hospital Basel's Liechti Laboratory and Aims To Enhance Therapeutic Potential of Psychedelics Tue, 21 Apr 2020 20:06:05 GMT https://www.biospace.com/psychedelic-pharmaceutical-company-mindmed-develops-lsd-neutralizer-technology-to-shorten-and-stop-lsd-trips https://www.biospace.com/mindmed-adds-mdma-to-develop-next-gen-psychedelic-therapies MindMed Further Expands R&D Collaboration with University Hospital Basel's Liechti Lab with Plans To Develop Next-Gen Psychedelic Therapies Combining LSD and MDMA Wed, 27 May 2020 11:06:19 GMT https://www.biospace.com/mindmed-adds-mdma-to-develop-next-gen-psychedelic-therapies